Suggested Topics within your search.
Suggested Topics within your search.
- COVID-19 8
- COVID-19 (Disease) 8
- Clinical trials
- SARS-CoV-2
- prevention & control
- Clinical Trials as Topic 6
- Coronavirus infections 6
- Development 6
- Pneumonia, Viral 6
- COVID-19 Vaccines 4
- Treatment 4
- Vaccination 4
- Vaccines 4
- administration & dosage 4
- immunology 4
- therapeutic use 4
- Antibodies, Viral 2
- Antiviral Agents 2
- Antiviral agents 2
- Betacoronavirus 2
- Blood Donors 2
- Blood plasma 2
- ChAdOx1 COVID-19 vaccine 2
- Chemotherapy 2
- Clinical Trials, Phase II as Topic 2
- Immunization, Passive 2
- Interferon 2
- Interferon-beta 2
- Nebulizers and Vaporizers 2
- Pharmacovigilance 2
-
1
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Published 2020Get full text
Series
Electronic Audio -
2
The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /
Published 2020Get full text
Series
Electronic Audio -
3
Imperial College London's saRNA Vaccine - COVAC1
Published 2020Get full text
Series
Electronic Audio -
4
Convalescent plasma therapy as a treatment for COVID-19
Published 2020Get full text
Series
Electronic Audio -
5
Convalescent plasma therapy as a treatment for COVID-19
Published 2020Get full text
Series
Electronic Audio -
6
Imperial College London's saRNA Vaccine - COVAC1
Published 2020Get full text
Series
Electronic Audio -
7
The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /
Published 2020Get full text
Series
Electronic Audio -
8
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Published 2020Get full text
Series
Electronic Audio
